Secondary headache: giant cell arteritis, intracranial hypertension and postdural puncture
Headache and orofacial pain · C7 · Reviewed by a board-certified pain physician on November 2, 2026
Bottom line
A new headache with red flags needs its cause found quickly: suspected giant cell arteritis is treated before confirmation, papilledema needs urgent imaging and venography before lumbar puncture, and refractory postdural puncture headache needs a blood patch.
Key points
- Treat strongly suspected arteritis at once. New temporal headache with jaw claudication or a high ESR in an older adult raises suspicion; with strong suspicion, start glucocorticoids without waiting for confirmation and refer for specialist assessment within 24 hours 1.
- Arteritis needs a higher steroid dose. The starting dose for giant cell arteritis is 40–60 mg/day prednisone-equivalent, versus 15–25 mg/day for polymyalgia rheumatica 1.
- Papilledema: image within 24 hours. Urgent brain MRI should show no hydrocephalus, mass, structural or vascular lesion or abnormal meningeal enhancement; CT or MR venography is mandatory to exclude venous sinus thrombosis 2.
- Lumbar puncture comes after normal imaging. All patients with papilledema should then have opening pressure measured in the lateral decubitus position and cerebrospinal fluid contents checked 2.
- Postdural puncture headache: conservative care first. Multisociety consensus guidelines frame management around conservative measures, with an epidural blood patch for disabling or refractory symptoms 3.
- The blood patch is the gold standard. For headache refractory to conservative measures it should be used without undue delay when there are no contraindications; the consensus guidelines do not support routine sphenopalatine ganglion block 4.
Watch for
In suspected idiopathic intracranial hypertension, a sixth nerve palsy is compatible with the diagnosis, but involvement of other cranial nerves should prompt a search for another cause 2.
High-yield for the exam
- Temporal artery biopsy and other confirmatory tests proceed while glucocorticoid treatment for giant cell arteritis continues 1.
- Interleukin-6 receptor inhibitors are an option for selected patients with polymyalgia rheumatica or giant cell arteritis 1.
- For most patients with suspected polymyalgia rheumatica, glucocorticoids can wait until the diagnosis is confirmed 1.
- Caffeine is one of the conservative measures for postdural puncture headache; the sphenopalatine ganglion block has weaker evidence 4.
- Venography in suspected intracranial hypertension is done within 24 hours, alongside MRI, to exclude cerebral venous sinus thrombosis 2.
- Suspected polymyalgia rheumatica, giant cell arteritis or Takayasu arteritis should all receive specialist assessment 1.
- Postdural puncture headache is orthostatic and results from cerebrospinal fluid leak after dural puncture 3.
Numbers to know
| Item | Value |
|---|---|
| Giant cell arteritis starting dose | 40–60 mg/day prednisone-equivalent 1 |
| Polymyalgia rheumatica starting dose | 15–25 mg/day 1 |
| Specialist referral for suspected arteritis | Within 24 hours 1 |
| MRI and venography for papilledema | Within 24 hours 2 |
| Lumbar puncture position for opening pressure | Lateral decubitus 2 |
Common traps
- Waiting for a temporal artery biopsy before starting steroids when arteritis is strongly suspected 1.
- Performing lumbar puncture before brain imaging and venography in papilledema 2.
- Using a sphenopalatine ganglion block instead of a blood patch for refractory postdural puncture headache 4.
- Treating isolated polymyalgia rheumatica with the higher arteritis dose 1.
Practise this topic
4 more questions on this topic in the full question bank, with explanations and sources.
Sources
- Mukhtyar CB, et al. 2025 EULAR recommendations for the management of polymyalgia rheumatica and primary large vessel vasculitis. Ann Rheum Dis, 2026. pubmed.ncbi.nlm.nih.gov/42481270/
- Mollan SP, et al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry, 2018. pmc.ncbi.nlm.nih.gov/articles/PMC6166610/
- Uppal V, et al. Consensus Practice Guidelines on Postdural Puncture Headache From a Multisociety, International Working Group: A Summary Report. JAMA Netw Open, 2023. pubmed.ncbi.nlm.nih.gov/37581893/
- Thon JN, et al. Efficacy of therapies for post dural puncture headache. Curr Opin Anaesthesiol, 2024. pmc.ncbi.nlm.nih.gov/articles/PMC11062605/
Related topics
Independent study material for the ABA Pain Medicine exam, written and reviewed by a board-certified pain physician. Not medical advice; not affiliated with the American Board of Anesthesiology.